One of our fearless leaders, Megan Livingston, sat on a panel at INTERPHEX Global's annual conference in NYC earlier this week to discuss how the vaccine industry is leading the way for innovative needle-free technologies, like our thin films. You can read about the technologies included and the panel's discussion at the link below. https://lnkd.in/ekXSFyJT
Jurata Thin Film的动态
最相关的动态
-
???Join Us for an Exciting Webinar on Allyship!??? We are thrilled to invite you to our upcoming Latinos in Bio webinar, where we will dive deep into the crucial topic of allyship. This is an amazing opportunity to engage in meaningful discussions, share insights, and learn how to be a better ally in both personal and professional settings. Don’t miss out on this chance to be part of a transformative conversation. Register now and be a part of the change! ?? Register using the link below Looking forward to seeing you there! #Allyship #Webinar #DiversityAndInclusion #ProfessionalDevelopment
SAVE THE DATE! ? Join us for an impactful virtual panel discussion, "Catalyzing Change: Allyship and Latinx Representation in Biopharma", co-hosted by Novo Nordisk and Latinos in Bio, where we'll explore the role of allyship in advancing Latinx representation in the biopharma industry. This panel will cover key insights on breaking barriers, building partnerships, and fostering a more inclusive industry for all. Panel Details ?? Date: Friday, December 6, 2024 ?? Time: 12:00pm - 1:00pm US ET ?? Location: Virtual (Link will be provided after registration) Reserve your virtual seat for this powerful conversation. After registering, you will receive a link to join the session. Registration Link: https://lnkd.in/eB3c8i9J We look forward to seeing you there! Daniela Camelo, Carolina Alarco, Gisselle Perez, Fernanda Gamero, Zaza Farrell, Melissa Harakuni, RD, CDCES, Melinda Benavides #Biopharma #LatinxRepresentation #AllyshipInAction #InclusiveIndustry #BreakingBarriers #BuildingPartnerships #LifeSciences #VirtualPanel #JoinTheConversation
要查看或添加评论,请登录
-
-
CEO @ Medical Funding Professionals, a Registered Investment Advisory Firm - Capital planning for Reg A+, Reg D (506c & 506b), State 504, S-1 for IPO's, VC, Private Equity, Hedge Funds, Family Offices
While the biotech industry has been facing a downturn the last couple of years, some big biotech names have been able to capitalize on their landmark products to launch new innovative projects. Faced with financial challenges, the leaders of the industry have been able to adapt to the changing dynamics of the market. At a time when the industry is?set to recover, the companies in this list will play an important role in the developments of this year and beyond. Here are the fourteen biotech companies with a market capitalization above $100 billion.
Fourteen biotech companies with market caps exceeding $100 billion
https://www.labiotech.eu
要查看或添加评论,请登录
-
Welcome to the NLSDays 2024 in Malm?! This significant event, the Nordic Life Science Days 2024, will return to Malm?, Sweden, on 18-19 September. We will be exhibiting at this great event! Nubilaria, stand number C04. We are also a presenter at conference. Date: 18 September 2024 Time: 14:15 Location: Main Hall Our colleagues Franco Schiannini and Erich Cavicchiolo are excited to have you at this prestigious event and are looking forward to your presence! https://lnkd.in/d4VHZKyZ #clinicalresearch #healthcaredata #healthcareit #healthcaresoftware #data #healthcare #pharmaceuticals #digitalhealthcare #pharmaceuticaltechnology #clinicalresearch #clinicaltrials #digitalhealth #healthtechnology #healthtech #clinicalresearch #clinical #cro #clinicaldata #clinicaltrialmanagement #clinicalstudies #clinicaldataplatforms #remotehealthcare #remotehealth #clinicaloperations #clinicaldevelopment #clinicaloperations #clinicaldata #remotemonitoring #datamanagementplatform #datamanagement #pharma #lifescience #rwe #rwd #epro #sops #etmf #edc #sdv #edc #cra #rtsm #sae #uat #gcp #qa #ecoa #iwrs #esource #econsent #decentralizedtrials #decentralizedstudies
NLS Days Event | Nubilaria Actide
https://actide.com
要查看或添加评论,请登录
-
??Swipe and Share! As we close out of our final day at DigiPharma Connect 2024, we'd like to thank all of our attendees, sponsors, and speakers contributed to making this one of the most engaging, insightful, and network-driven events in the biotech and pharma space among senior-level executives! #DigiPharmaConnect2024 #DigiPharmaConnect #DigiPharma24
要查看或添加评论,请登录
-
Kicking off #DCATWeek, six key industry leaders gathered for a round table to discuss their respective companies’ participation and share industry views. Hayley Crowe, Ecolab EVP & GM, Global Life Sciences, was among the participants involved in the discussion. Read their perspectives in the article from the Life Sciences Knowledge Hub. #DCAT | #DCATWeek2024
Views from a round table at DCAT Week
https://www.lskh.digital
要查看或添加评论,请登录
-
Excited for the Pharma CI Conference in Newark! I’ll be representing SI Insights at this year’s Pharma CI conference and am looking forward to connecting with fellow professionals. Here’s what you can expect from us: ?? Comprehensive Coverage of the Indian, African, and Southeast Asian pharma markets for your consulting and competitive intelligence (CI) needs. ?? Expertise in US and EU pharma markets for tailored CI projects. Whether you're looking for insights, collaboration, or new opportunities, I’d love to meet and discuss how SI Insights can support your pharma CI and consulting goals. Let’s connect! ?? #PharmaCI #PharmaConsulting #CompetitiveIntelligence #SIInsights #PharmaMarkets #IndiaPharma #AfricanPharma #SoutheastAsiaPharma #USPharma #EUPharma #PharmaExpertise
?? Meet Our Team at Pharma CI Conference & Exhibition, USA, 2024! ?? We are thrilled to announce that our team will be attending the Pharma CI event in Newark, NJ, USA, on September 25-26, 2024! ?? #PharmaCI2024 #CompetitiveIntelligence #PharmaIndustry #MarketResearch #BusinessCollaboration #SIInsights
要查看或添加评论,请登录
-
-
Register for tomorrow’s Webinar. Learn insights to help your team create trials that not only meet regulatory and scientific standards, but also align with the needs and experiences of patients.
It’s not too late! Join us TOMORROW for an important discussion with Novo Nordisk's Rasmus Enggaard, Regeneron's Michael Pazian, Thrivable's Maria Muccioli, and YPrime’s Michael Hughes. Discover the power of putting patients first in trial design: https://lnkd.in/eYGubnAG
要查看或添加评论,请登录
-
-
?????? ???????????? ?????? ?????????????????? ???? ????????????????! ?? Anocca hosted a workshop during the NLSDays 2024 conference, exploring the potential of ???????? ?????? ???????? ?????????????? (??????) in the region. Industry leaders from NorthX Biologics, AstraZeneca, and CCRM Nordic discussed the opportunities, challenges, and collaborations needed to drive innovation and increase efficiency in this high-tech field. Key takeaways: ?????????????????????????? ???? ??????: Partnerships between academia, industry, and government are essential for advancing CGT. ???????????? ???? ??????????????: Attracting and retaining top talent is vital for the growth of the Nordic CGT ecosystem. ?????????????????????????????? ???? ??????????????????: Developing clear standards and guidelines can streamline product development and manufacturing. Read the full article, written by Daniel Gooch from Scius Communications: https://lnkd.in/dMH5RA9t #CGT #NLSDays #Biotech #Innovation #Collaboration #Healthcare
要查看或添加评论,请登录
-
-
Insightful discussion on the value of partnerships at Executive Insights 2024 Emphasizing that partnerships are critical for successful drug development, especially for small companies like BioArctic that rely on collaborations, Gunilla Osswald, BioArctic CEO, was one of the speakers at the Executive Insights 2024 conference hosted by Cytel, DNB, and Flerie. Osswald values partners who are truly interested in working together cooperatively to achieve strong relationships and added a sixth "R" to the classic 5R concept in pharma negotiations - focusing on the significance of relationships and their ability to advance innovation. The six Rs: - Right target - Right patient population - Right dose and exposure - Right study design - Right safety - Right collaborations
要查看或添加评论,请登录
-